If you are ready to simplify and reduce the time it takes to connect with reporters for the research and innovation at your institution, we are here for you.
New research in The FASEB Journal indicates that expression levels of the RPGRIP1L gene might serve as a new prognostic marker for individuals with invasive breast cancer.
Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting, which will be held at the Walter E. Washington Convention Center in Washington, D.C., September 29 – October 2, 2024. Led by ASTRO President Howard Sandler, MD, FASTRO, the conference is expected to attract up to 10,000 oncologists, clinicians, researchers and other health care professionals from around the globe. Media registration is also available.
At the Toronto Pearson International Airport, airplane traffic dropped by 80% in the first few months of lockdown during the COVID-19 pandemic., and in early 2020, the NVH-SQ Research Group out of the University of Windsor surveyed residents living around the airport to gauge how their annoyance levels changed with the reduction in noise.
Systemic treatment of cancer patients near end of life does not improve survival rates, according to a new study from researchers at Yale Cancer Center (YCC) and The University of Texas MD Anderson Cancer Center. The study, which joins a growing body of research on end-of-life cancer treatment, published May 16 in JAMA Oncology.
A new study conducted by a team of researchers from China and the UK provides crucial insights into the variation of dissolved organic matter (DOM) during the South-to-North Water Diversion in China and its implications for drinking water treatment.
In what they believe is a solution to a 30-year biological mystery, neuroscientists at Johns Hopkins Medicine say they have used genetically engineered mice to address how one mutation in the gene for the light-sensing protein rhodopsin results in congenital stationary night blindness.